CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Iptacopan (LNP023)

Phase 3
Novartis AG (NVS)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
NVSPhase 2
✗Negative

Iptacopan (LNP023) Phase 2 Est. Readout

Iptacopan (LNP023)
Oct 2026~
CT.gov
Competitive Landscape

0 competitors in Paroxysmal Nocturnal Hemoglobinuria (PNH)

View Full Landscape
Drug Information

Target Indication

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Clinical Trial

NCT04820530

Last updated: 1/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.